SCHEMBL30949406

SCHEMBL30949406

CC(=O)/C=C/C=C/C=C/C=C/c1cccnc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.60
▸ RAB9A P51151 3/20 0.60
▸ NPC1 O15118 2/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ JUN P05412 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ GPR55 Q9Y2T6 1/20 0.60
▸ LMNA P02545 2/20 0.55
▸ APAF1 O14727 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ PFKFB3 Q16875 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ KMT2A Q03164 1/20 0.50
▸ CYP1A1 P04798 6/20 0.49
▸ CYP1A2 P05177 6/20 0.49
▸ CYP1B1 Q16678 6/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6848209 0.86 RAB9A (0.73) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL6848207 0.86 RAB9A (0.73) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL5468275 0.83 MAPT (0.64) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL5468278 0.83 MAPT (0.64) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL82827 0.82 RAB9A (0.62) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL1374180 0.79 GLA (0.70) MAPTNPC1MAPK1LMNAPOLB
SCHEMBL31349694 0.79 GLA (0.70) MAPTNPC1MAPK1LMNAPOLB
SCHEMBL735374 0.79 GLA (0.70) MAPTNPC1MAPK1LMNAPOLB
SCHEMBL5962608 0.78 RAB9A (0.53) MAPTRAB9ANPC1KDM4EJUN
SCHEMBL5962606 0.78 RAB9A (0.53) MAPTRAB9ANPC1KDM4EJUN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652196-A1 NEUROPILIN-1-PEPTIDE BASED ANTIBODY, HIGHLITING NEW EPITOPE ASSOCIATED TO GLYCOSAMINOGLYCAN-MODIFIED NEUROPILIN-1 AND METHODS OF USE THEREOF Theranovir (FR) 2025-11-26 — — EP disclosed
WO-2024153818-A1 NEUROPILIN-1-PEPTIDE BASED ANTIBODY, HIGHLITING NEW EPITOPE ASSOCIATED TO GLYCOSAMINOGLYCAN-MODIFIED NEUROPILIN-1 AND METHODS OF USE THEREOF Theranovir (FR) 2024-07-25 — — WO disclosed
Send feedback